https://www.marketscreener.com/quote/stock/ZYDUS-LIFESCIENCES-LIMITE-34067618/valuation/
Zydus Lifesciences Limited: Valuation Ratios, Analysts' Forecasts - MarketScreener
Find analyst estimates regarding the valuation of Zydus Lifesciences Limited. Enterprise Value, P/E Ratio, PEG, FCF, and many other Ratios. The entire stock...
zydus lifescienceslimitedvaluationratiosanalysts
https://www.ad-hoc-news.de/boerse/news/ueberblick/zydus-lifesciences-aktie-pipeline-hoffnung/68612435
Zydus Lifesciences Aktie: Pipeline-Hoffnung
Der indische Pharmakonzern fokussiert sich nach juristischer Bereinigung auf die US-Zulassung von Saroglitazar Magnesium und den Ausbau seiner...
zydus lifesciencesaktiepipelinehoffnung
https://www.marketscreener.com/news/zydus-lifesciences-receives-tax-demand-penalty-of-32-8-mln-rupees-ce7e5ed3db8cf225
Zydus Lifesciences receives tax demand penalty of 32.8 mln rupees | MarketScreener
Mar 25, 2026 - Zydus Lifesciences Ltd: Receives tax demand penalty of 32.8 million rupees ...
zydus lifesciences
https://www.marketscreener.com/news/zydus-lifesciences-says-tax-demand-of-41-77-million-rupees-dropped-ce7e51d2d18df325
Zydus Lifesciences says tax demand of 41.77 million rupees dropped | MarketScreener
Apr 6, 2026 - Zydus Lifesciences Ltd: Zydus Lifesciences - tax demand of 41.77 million rupees dropped ...
zydus lifesciences
https://www.business-standard.com/amp/markets/capital-market-news/zydus-lifesciences-receives-usfda-approval-for-ketoconazole-shampoo-2-125031000172_1.html
Zydus Lifesciences receives USFDA approval for Ketoconazole Shampoo, 2% | Capital Market News -...
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Ketoconazole Shampoo, 2% (USRLD:...
zydus lifesciences
https://www.business-standard.com/markets/capital-market-news/zydus-lifesciences-receives-usfda-approval-for-methenamine-hippurate-tablets-125031200456_1.html
Zydus Lifesciences receives USFDA approval for Methenamine Hippurate Tablets | Capital Market News...
Zydus Lifescienceshas received final approval from the United States Food and Drug Administration (USFDA) to manufacture Methenamine Hippurate Tablets USP, 1...
zydus lifesciences
https://www.prnewswire.com/news/zydus-lifesciences-ltd/
Zydus Lifesciences Ltd News and Press Releases | PR Newswire
news and press releaseszydus lifesciencesltdnewswire
https://www.businesstoday.in/stocks/zydus-lifesciences-ltd-zyduslife-share-price-364882
Zydus Lifesciences Ltd Share Price Today, ZYDUSLIFE Share Price NSE, BSE
Zydus Lifesciences Ltd Share price NSE, BSE today: check share/stock price of ZYDUSLIFE, get live NSE/BSE stock price of Zydus Lifesciences Ltd with financial...
zydus lifesciencesshare priceltdtodaynse
https://www.marketscreener.com/news/zydus-lifesciences-limited-launches-semaglutide-injection-in-innovative-reusable-multi-dose-pen-devi-ce7e51dad081f72c
Zydus Lifesciences Limited Launches Semaglutide Injection in Innovative Reusable Multi-Dose Pen...
Mar 21, 2026 - Zydus Lifesciences Limited has launched Semaglutide Injection under the brand names ? SEMAGLYNTM, MASHEMATM and ALTERMETM, upon patent expiry in India. The...
zydus lifesciencessemaglutide injection
https://www.ndtvprofit.com/business/zydus-lifesciences-csir-cdri-partner-to-develop-drug-for-ckd-induced-osteoporosis-9962785
Zydus Lifesciences, CSIR-CDRI Partner To Develop Drug For CKD-Induced Osteoporosis
Chronic kidney disease, which affects over 10% of the global population, leads to a gradual decline in kidney function and can result in kidney failure.
zydus lifesciencesto develop
https://www.marketscreener.com/news/zydus-lifesciences-launches-semaglutide-injection-in-reusable-multi-dose-pen-device-in-india-priced-ce7e5edfd08ffe27
Zydus Lifesciences launches semaglutide injection in reusable multi-dose pen device in India,...
Mar 21, 2026 - Zydus Lifesciences Ltd: Zydus Lifesciences launches semaglutide injection in reusable multi-dose pen device in India Zydus Lifesciences has exclusive rights to...
zydus lifesciencessemaglutide injection
https://www.livemint.com/zydus-lifesciences/bonus/companyid-s0003150
Zydus Lifesciences Bonus: Zydus Lifesciences Bonus Shares, Bonus Issue, Upcoming Zydus Lifesciences...
Zydus Lifesciences Bonus: Find out Zydus Lifesciences Bonus Shares and Upcoming Bonus Issues. Stay Informed and Maximize Your Investments with Our Trusted...
zydus lifesciencesbonus sharesissueupcoming
https://www.marketscreener.com/news/zydus-lifesciences-receives-final-usfda-approval-for-dapagliflozin-tablets-ce7e50dada8ef625
Zydus Lifesciences receives final USFDA approval for dapagliflozin tablets | MarketScreener
Apr 8, 2026 - Zydus Lifesciences Ltd: Receives final USFDA approval for dapagliflozin tablets ...
zydus lifesciencesreceivesfinalusfdaapproval
https://www.marketscreener.com/news/zydus-lifesciences-launches-new-inhaler-for-asthma-copd-patients-ce7e5ed9d089f725
Zydus Lifesciences Launches New Inhaler for Asthma, COPD Patients | MarketScreener
Mar 19, 2026 - Zydus Lifesciences has launched Aerolife Mini, a next-generation pressurized metered-dose inhaler enhancer, according to a Thursday filing to the Indian stock...
zydus lifescienceslaunchesnewinhalerasthma
https://www.republicworld.com/business/industry/zydus-lifesciences-gets-usfda-nod-for-heart-failure-treatment-drug
Zydus Lifesciences gets USFDA nod for heart failure treatment drug | Republic World
Jul 10, 2024 - Sacubitril and Valsartan combination is used to treat chronic heart failure in adults to help reduce the risk of death and hospitalisation.
heart failure treatmentzydus lifesciences
https://www.business-standard.com/amp/markets/capital-market-news/zydus-lifesciences-receives-usfda-tentative-approval-for-diroximel-fumarate-delayed-release-capsules-124071000698_1.html
Zydus Lifesciences receives USFDA tentative approval for Diroximel Fumarate Delayed-Release...
Zydus Lifesciences has received tentative approval from the United States Food and Drug Administration (USFDA) to market Diroximel Fumarate Delayed-Release...
zydus lifesciencesdiroximel fumaratereceivesusfdatentative
https://www.ndtvprofit.com/business/zydus-lifesciences-gujarat-plant-receives-official-action-indicated-notice-from-usfda-9985355
Zydus Lifesciences' Gujarat Plant Receives USFDA 'Official Action Indicated' Notice
The USFDA has determined that the inspection classification of the injectables manufacturing facility in Gujarat is 'Official Action Indicated'.
zydus lifesciencesgujaratplantreceivesusfda
https://www.marketscreener.com/news/zydus-lifesciences-secures-us-fda-nod-for-dapagliflozin-tablets-ce7e50dada81f324
Zydus Lifesciences Secures US FDA Nod for Dapagliflozin Tablets | MarketScreener
Apr 8, 2026 - Zydus Lifesciences has received final approval from the US Food and Drug Administration for Dapagliflozin Tablets in the strengths 5 mg and 10 mg, according to...
zydus lifesciencessecuresfdanoddapagliflozin
https://www.businesswire.com/news/home/20260115063777/nl
Agenus kondigt afronding aan van strategische samenwerking van $ 141 miljoen met Zydus Lifesciences...
Agenus Inc. ( Nasdaq: AGEN ), een leider in immuno-oncologische innovatie, kondigde vandaag de afronding aan van zijn eerder bekendgemaakte strategische same...
https://www.business-standard.com/markets/capital-market-news/zydus-lifesciences-ltd-slips-for-fifth-straight-session-124053000948_1.html
Zydus Lifesciences Ltd slips for fifth straight session | Capital Market News - Business Standard
Zydus Lifesciences Ltd is quoting at Rs 1024.9, down 1.9% on the day as on 13:19 IST on the NSE. The stock jumped 104.04% in last one year as compared to a...
https://www.business-standard.com/amp/companies/news/zydus-lifesciences-unit-gets-10-observations-from-usfda-after-inspection-124042400362_1.html
Zydus Lifesciences unit gets 10 observations from USFDA after inspection | Company News - Business...
Zydus Lifesciences on Wednesday said the US health regulator has issued ten observations after inspecting its injectable manufacturing plant near Vadodara in...
https://www.business-standard.com/companies/news/zydus-lifesciences-gets-china-nod-for-drug-to-treat-ckd-linked-anaemia-124042300752_1.html
Zydus Lifesciences gets China nod for drug to treat CKD-linked anaemia | Company News - Business...
It is estimated that more than 120 million people are living with chronic kidney disease in China
https://www.business-standard.com/companies/news/zydus-lifesciences-gets-4-observations-from-usfda-for-gujarat-plant-124032700780_1.html
Zydus Lifesciences gets 4 observations from USFDA for Gujarat plant | Company News - Business...
Zydus Lifesciences on Wednesday said the US health regulator has issued a Form-483 with four observations following the inspection of its Ahmedabad-based SEZ...
https://www.business-standard.com/amp/markets/news/here-s-why-zydus-lifesciences-share-price-popped-3-in-trade-on-march-19-125031900280_1.html
Here's why Zydus Lifesciences share price popped 3% in trade on March 19 | Markets News - Business...
The rise in the Zydus Lifesciences share prices came after the company received final approval from the United States Food and Drug Administration (USFDA) to...
https://www.businesswire.com/news/home/20250603886947/nl
Agenus en Zydus Lifesciences gaan strategische samenwerking van $ 141 miljoen aan om BOT/BAL te...
Agenus Inc. (Nasdaq: AGEN), een leider in innovatie op het gebied van immuno-oncologie, heeft vandaag aangekondigd dat het definitieve samenwerkingsovereenko...
https://www.marketscreener.com/news/zydus-lifesciences-receives-demand-order-for-fy-2019-20-to-fy-2023-24-ce7e51dfdb8df422
Zydus Lifesciences receives demand order for FY 2019-20 to FY 2023-24 | MarketScreener
Apr 1, 2026 - Zydus Lifesciences Ltd: Receives demand order for FY2019-20 to FY2023-24 Gets tax demand order worth 14.2 million rupees ...
https://www.marketscreener.com/news/zydus-lifesciences-launches-aerolife-mini-to-simplify-inhaler-use-for-asthma-and-copd-patient-ce7e5ed9d08cf02c
Zydus Lifesciences launches Aerolife mini, to simplify inhaler use for asthma and COPD patient |...
Mar 19, 2026 - Zydus Lifesciences Ltd: Zydus launches Aerolife mini, to simplify inhaler use for asthma and COPD patient ...
https://www.ndtvprofit.com/markets/stocks-to-watch-today-airtel-vodafone-idea-power-grid-titan-sbi-zydus-lifesciences-9570374
Stocks To Watch Today: Airtel, Vodafone Idea, Power Grid, Titan, SBI, Zydus Lifesciences
Shares of Suzlon Energy, Whirlpool Of India will also be in focus ahead of financial result announcements.
stocks to watch
https://www.business-standard.com/markets/news/here-s-why-zydus-lifesciences-share-price-was-buzzing-in-trade-on-march-17-125031700123_1.html
Here's why Zydus Lifesciences share price was buzzing in trade on March 17 | Markets News -...
The uptick in the Zydus Life share price came after the company received final approval from the USFDA to manufacture Eluxadoline Tablets, 75 mg and 100 mg